April, 2024
April 2024
OncoDaily Dialogues #7: Aparna Parikh / Hosted by Roupen Odabashian
Mar 23, 2024, 15:29

OncoDaily Dialogues #7: Aparna Parikh / Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues,”we consistently feature prominent individuals in the field of oncology. We showcase their achievements, obstacles they’ve overcome, and significant moments in their journey.

Today, we’re honored to have Aparna Parikh, a renowned GI oncologist, the Director of the Global Cancer Care Program at Mass General, and also an assistant professor at Harvard Medical School. Get ready for an insightful conversation you won’t want to miss!

In this episode of OncoInfluencers, we explore Dr. Parikh’s journey into oncology, her dedication to research and treatment in gastrointestinal cancers, and her insights into advancing patient care. Discover valuable advice for success in oncology, the pivotal role of leadership and mentorship, and the evolving landscape of clinical research and treatment protocols. Don’t miss this engaging discussion with one of the brightest minds shaping the future of oncology.

About Aparna Parikh

Dr. Aparna Parikh is a distinguished GI oncologist, renowned for her expertise in gastrointestinal cancers. As the Director of the Global Cancer Care Program at Mass General and an assistant professor at Harvard Medical School, Dr. Parikh has dedicated her career to advancing cancer care globally. With extensive involvement in global health, she has worked in various African countries, Haiti, and India, focusing on improving access to quality cancer care and education.

She co-founded and co-leads the POETIC fellowship exchange program, which trains clinical oncology fellows from South Africa and Tanzania. Additionally, as a member of the executive board of BOTSOGO, she collaborates with partners to improve access to quality cancer care in Botswana through education, training, and vital clinical research.

Recognized as a leading expert in gastrointestinal cancers, Dr. Parikh’s contributes to the NCCN guidelines for colorectal cancer and directs clinical trials within the GI oncology program at Mass General. Dr. Parikh’s research focuses on introducing innovative treatments for colorectal and pancreatic cancer, advancing the study of these diseases, and improving patient outcomes.

Dr. Parikh’s work extends to liquid biopsy initiatives within the GI Oncology group. She is globally recognized for her expertise in liquid biopsies, which play a crucial role in assessing residual disease post-surgery, evaluating treatment responses, and understanding drug resistance mechanisms. Her research efforts contribute to refining diagnostic tools and improving patient care in oncology.

Dr. Parikh remains deeply committed to addressing disparities in cancer care, particularly in low- and middle-income countries. She champions initiatives focused on enhancing access, equity, and education in these regions, striving to make a meaningful impact on the lives of cancer patients worldwide. Her dedication to advancing research and enhancing patient care has established her as a prominent figure in the field. Dr. Parikh was also recognized in OncoDaily’s 100 Influential Women in Oncology in 2023.

About Roupen Odabashian

Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.

In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout. With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.

About OncoDaily

OncoDaily.com was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally. OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”.

Previous episodes of OncoInfluencers

Episode 1: OncoInfluencers: Dialogue with Françoise Meunier, hosted by Gevorg Tamamyan

Episode 2: OncoInfluencers: Dialogue with Dean Crowe, hosted by Gevorg Tamamyan

Episode 3: OncoInfluencers: Dialogue with Nagashree Seetharamu, hosted by Gevorg Tamamyan

Episode 4: OncoInfluencers: Dialogue with Julie Gralow, hosted by Gevorg Tamamyan

Episode 5: OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan